Alkermes
near term expected revenue drivers current proprietary commercial products alcohol dependence prevention of relapse to dependence following detoxification expected net sales schizophrenia under review june schizophrenia bipolar i disorder potential launch royalty stream commercialized by biogen relapsing forms of multiple sclerosis launched in these expectations and the underlying assumptions and risks are set forth in the company filed with the sec on the company expressly disclaims any obligation to update or reaffirm these expectations full indication and prescribing information for may be found at full prescribing information for may be found at | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
23 of 144
Similar slides by Alkermes
See diffirences between slides (animation)
Investor Day
March 2021
expected growth drivers net sales patent life indications alcohol dependence prevention of relapse to dependence following detoxification schizophrenia schizophrenia bipolar i disorder potential launch in current proprietary commercial products proprietary candidate under review june licensed product royalty manufacturing revenue commercialized by biogen relapsing forms of multiple sclerosis launched in under the terms of a settlement and license agreement entered into in with pharmaceuticals alkermes granted a non exclusive license under certain patents covering including the remaining patent covering in the to market and sell a generic formulation of in the beginning sometime in or under certain circumstances subject to paragraph certification related to an anda seeking approval of a generic version a patent infringement lawsuit has been filed against the paragraph filer in response full indication and prescribing information for may be found at full prescribing information for may be found at injectable suspension | Alkermes
Related slides by other companies
Myovant Sciences
Results
August 2022
overview of prescribing information for | Myovant Sciences
OpenText
Investor Presentation
November 2022
the information company | OpenText
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io